Skip to main content
. Author manuscript; available in PMC: 2017 Feb 28.
Published in final edited form as: J Control Release. 2015 Dec 28;224:69–76. doi: 10.1016/j.jconrel.2015.12.044

Figure 8.

Figure 8

Pharmacokinetic profile of ziconotide in plasma following intranasal administration of ziconotide KP 407 without chitosan (X), with chitosan (+), ziconotide solution with chitosan (■) without chitosan (◆), i.v (▲) and intrathecal (●) administration of ziconotide solution.